11.08
-0.78(-6.58%)
Currency In USD
Address
300 5th Avenue
Waltham, MA 02451
United States of America
Phone
617-430-5595
Sector
Healthcare
Industry
Biotechnology
Employees
33
First IPO Date
January 10, 2014
| Name | Title | Pay | Year Born |
| Joshua T. Brumm | CEO & Director | 0 | 1978 |
| Ellie Im | Chief Medical Officer | 0 | 1978 |
| Jan Pinkas | Chief Scientific Officer | 0 | N/A |
| Jonathan McNeill | President & Chief Operating Officer | 0 | 1985 |
| Wenjie Cheng | Senior Vice President of Technical Operations | 0 | N/A |
| Christopher Doughty | Chief Business Officer | 0 | 1987 |
| Richard William Scalzo | Chief Financial Officer | 0 | 1986 |
| Ryan Lynch | Senior Vice President of Finance, Treasurer & Chief Accounting Officer | 0 | 1984 |
| Amy Reilly | Chief Communications Officer | 0 | 1973 |
| Barbara H. Bispham | General Counsel & Corporate Secretary | 0 | 1986 |
| Tanya Sengupta | Executive VP and Chief of Strategy & Operations | 0 | N/A |
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.